{"version":"1.0","type":"link","title":"Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenib.","author_name":"Massoud R 외","author_url":"https://prs-insight.online/author/Massoud%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/160550","thumbnail_width":1200,"thumbnail_height":630}